DD232045A5 - Verfahren zur herstellung von vorwirkstoffen entzuendungshemmender oxicame - Google Patents

Verfahren zur herstellung von vorwirkstoffen entzuendungshemmender oxicame Download PDF

Info

Publication number
DD232045A5
DD232045A5 DD85273451A DD27345185A DD232045A5 DD 232045 A5 DD232045 A5 DD 232045A5 DD 85273451 A DD85273451 A DD 85273451A DD 27345185 A DD27345185 A DD 27345185A DD 232045 A5 DD232045 A5 DD 232045A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
dioxide
carboxamide
formula
compound
Prior art date
Application number
DD85273451A
Other languages
German (de)
English (en)
Inventor
Joseph G Lombardino
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD232045A5 publication Critical patent/DD232045A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DD85273451A 1984-02-23 1985-02-21 Verfahren zur herstellung von vorwirkstoffen entzuendungshemmender oxicame DD232045A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58268484A 1984-02-23 1984-02-23

Publications (1)

Publication Number Publication Date
DD232045A5 true DD232045A5 (de) 1986-01-15

Family

ID=24330094

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85273451A DD232045A5 (de) 1984-02-23 1985-02-21 Verfahren zur herstellung von vorwirkstoffen entzuendungshemmender oxicame

Country Status (22)

Country Link
JP (1) JPS60184077A (it)
KR (1) KR850006198A (it)
AU (1) AU552478B2 (it)
BE (1) BE901783A (it)
DD (1) DD232045A5 (it)
DE (1) DE3505576A1 (it)
DK (1) DK81185A (it)
ES (1) ES8606312A1 (it)
FI (1) FI850742L (it)
FR (1) FR2565980A1 (it)
GB (1) GB2154585A (it)
GR (1) GR850442B (it)
HU (1) HUT37616A (it)
IL (1) IL74407A0 (it)
IT (1) IT1185514B (it)
LU (1) LU85780A1 (it)
NL (1) NL8500485A (it)
NO (1) NO850725L (it)
PL (1) PL252023A1 (it)
PT (1) PT79988B (it)
SE (1) SE8500889L (it)
ZA (1) ZA851317B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
US4610982A (en) * 1985-06-03 1986-09-09 Pfizer Inc. Anti-inflammatory benzo- and thieno-1,2-thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
CN101522692A (zh) * 2006-10-11 2009-09-02 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药
KR20180049144A (ko) 2007-06-04 2018-05-10 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(nsaia) 약물전구체 및 이들의 새로운 의약적 용도
JP2012511027A (ja) 2008-12-04 2012-05-17 チョンシー ユー 高透過性組成物およびその用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591574A (en) * 1968-05-29 1971-07-06 American Home Prod Tri-n-phenylglycyl derivatives of insulin
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3704298A (en) * 1971-06-22 1972-11-28 Warner Lambert Co 4-acyloxy-3-(2-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,1-dioxides
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
US4309427A (en) * 1981-01-15 1982-01-05 Pfizer Inc. Benzothiazine dioxide derivatives
IT8219486A0 (it) * 1982-02-05 1982-02-05 Chiesi Farma Spa Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1206525B (it) * 1982-12-10 1989-04-27 Zionale S R L A Roma Preparato anti-infiammatorio nonsteroideo, per il trattamento delle affezioni artroreumatiche e metodo per la sua preparazione

Also Published As

Publication number Publication date
FR2565980A1 (fr) 1985-12-20
FI850742A0 (fi) 1985-02-22
ES540590A0 (es) 1986-04-16
IT8519585A0 (it) 1985-02-21
ES8606312A1 (es) 1986-04-16
IL74407A0 (en) 1985-05-31
GB2154585A (en) 1985-09-11
JPS60184077A (ja) 1985-09-19
BE901783A (fr) 1985-08-21
HUT37616A (en) 1986-01-23
DE3505576A1 (de) 1985-09-05
NO850725L (no) 1985-08-26
PL252023A1 (en) 1985-11-05
DK81185D0 (da) 1985-02-22
PT79988B (en) 1987-02-02
KR850006198A (ko) 1985-10-02
AU3906685A (en) 1985-09-05
AU552478B2 (en) 1986-06-05
DK81185A (da) 1985-09-10
FI850742L (fi) 1985-08-24
SE8500889D0 (sv) 1985-02-22
GR850442B (it) 1985-06-19
NL8500485A (nl) 1985-09-16
ZA851317B (en) 1986-10-29
IT1185514B (it) 1987-11-12
SE8500889L (sv) 1985-08-24
PT79988A (en) 1985-03-01
LU85780A1 (fr) 1985-12-11
GB8504355D0 (en) 1985-03-20

Similar Documents

Publication Publication Date Title
DE2228012C3 (de) Phthalidester der 6- [D(-)- a Aminophenylacetamido] -penicillansäure und Verfahren zu seiner Herstellung
EP0658559A1 (de) Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
DE3331808A1 (de) Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE69429570T2 (de) Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
DE69834052T2 (de) Neue amidverbindungen und medikamente die diese enthalten
DE69319391T2 (de) 1,2,4-Oxadiazolyl oder 1,2,4-Thiadiazolyl-Derivate als Angiotensin II Antagonisten
DD232045A5 (de) Verfahren zur herstellung von vorwirkstoffen entzuendungshemmender oxicame
DE3730748A1 (de) Neue polyoxygenierte labdanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE68924221T2 (de) Imidazolderivate.
CH635092A5 (de) Verfahren zur herstellung neuer benzopyranderivate.
EP0102175A1 (en) 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use
EP0697405A1 (de) Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE68917333T2 (de) Heterocyclische Verbindungen und Antiulkusmittel.
EP0014390B1 (de) 2-Amino-8-cyclopropyl-5-oxo-5,8-dihydro-pyrido (2,3-d) pyrimidin-6-carbonsäuren, sie enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung
DE2812353A1 (de) Oxazol- und thiazol-alkansaeureverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
EP0657459A1 (de) Neue Thienothiazinderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Antiinflammatorikum und Analgeticum
EP0211157B1 (de) Isoxazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Präparate
DE1935404C3 (de) Verfahren zur Herstellung von Chinazoline nen
DD285604A5 (de) Verfahren zur herstellung von enol-ethern und estern
DE2612926A1 (de) Neue acyl-derivate der 6-(alpha- amino-phenylacetamido)-penicillansaeure
DD259401A5 (de) Verfahren zur herstellung von 2-alkylbenzimidazol-derivaten
NZ227163A (en) Pyrimidine derivatives and pharmaceutical compositions
EP0003360B1 (de) Neue Azathianaphthalinderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung
AT393269B (de) Verfahren zur herstellung von oxazino-(5,6-c)-1,2-benzothiazin-6,6-dioxid
DE69432801T2 (de) Verbindungen die als antiproliferierende mittel und garft inhibitoren verwendbar sind